Abstract:The transmembrane receptor for advanced glycation end products (RAGE) is a signaling receptor for many damage‐ and pathogen‐associated molecules. RAGE activation is associated with inflammation and an increase in reactive oxygen species (ROS) production, but how RAGE induces ROS production is still unclear. Here, using acute brain slices and primary co‐culture of cortical neurons and astrocytes, we show that specific activation of RAGE induces redox signaling through NADPH oxidase, which may be a part of a cell protective mechanism. The transmembrane receptor for advanced glycation end products (RAGE) is a signaling receptor for many damage‐ and pathogen‐associated molecules. Activation of RAGE is associated with inflammation and an increase in reactive oxygen species (ROS) production. Although several sources of ROS have been previously suggested, how RAGE induces ROS production is still unclear, considering the multiple targets of pathogen‐associated molecules. Here, using acute brain slices and primary co‐culture of cortical neurons and astrocytes, we investigated the effects of a range of synthetic peptides corresponding to the fragments of the RAGE V‐domain on redox signaling. We found that the synthetic fragment (60–76) of the RAGE V‐domain induces activation of ROS production in astrocytes and neurons from the primary co‐culture and acute brain slices. This effect occurred through activation of RAGE and could be blocked by a RAGE inhibitor. Activation of RAGE by the synthetic fragment stimulates ROS production in NADPH oxidase (NOX). This RAGE‐induced NOX activation produced only minor decreases in glutathione levels and increased the rate of lipid peroxidation, although it also reduced basal and β‐amyloid induced cell death in neurons and astrocytes. Thus, specific activation of RAGE induces redox signaling through NOX, which can be a part of a cell protective mechanism.

RAGE is a Nucleic Acid Receptor That Promotes Inflammatory Responses to DNA

RAGE Enhances TLR Responses Through Binding and Internalization of RNA.

RAGE during infectious diseases

Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors

Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases

132 : Sensing of DNA by innate immune receptors

Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

Toll-like receptor 9 – dependent activation by DNA-containing immune complexes is mediated by HMGB 1 and RAGE

DNA Sensing by Innate Immune Receptors (INM6P.408)

Pathophysiology of RAGE in inflammatory diseases

Data from RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma

HMGB1 and RAGE in Inflammation and Cancer

Coalescence of RAGE in Lipid Rafts in Response to Cytolethal Distending Toxin-Induced Inflammation

RAGE Is a Receptor for SARS-CoV-2 N Protein and Mediates N Protein-induced Acute Lung Injury

Rage Expression In Tumor-Associated Macrophages Promotes Angiogenesis In Glioma

RAGE induces physiological activation of NADPH oxidase in neurons and astrocytes and neuroprotection

RAGE regulation and signaling in inflammation and beyond

Histone serves as an eat-me signal to induce RAGE-mediated phagocytosis

Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction